These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24394737)

  • 61. Allergy to heparins and anticoagulants with a similar pharmacological profile: an update.
    Jappe U
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):605-13. PubMed ID: 17102645
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and safety of the long-term administration of low-molecular-weight heparins in pregnancy.
    Santoro R; Iannaccaro P; Prejanò S; Muleo G
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):240-3. PubMed ID: 19357505
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Weight-adjusted LMWH prophylaxis provides more effective thrombin inhibition in morbidly obese pregnant women.
    Ismail SK; Norris L; O'Shea S; Higgins JR
    Thromb Res; 2014 Aug; 134(2):234-9. PubMed ID: 24984985
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The laboratory control of anticoagulant thromboprophylaxis during the early postpartum period after cesarean delivery.
    Koltsova EM; Balandina AN; Grischuk KI; Shpilyuk MA; Seregina EA; Dashkevich NM; Poletaev AV; Pyregov AV; Sukhih GT; Serebriyskiy II; Ataullakhanov FI
    J Perinat Med; 2018 Apr; 46(3):251-260. PubMed ID: 28599392
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anticoagulation in pregnancy and the puerperium.
    Hague WM; North RA; Gallus AS; Walters BN; Orlikowski C; Burrows RF; Cincotta RB; Dekker GA; Higgins JR; Lowe SA; Morris JM; Peek MJ;
    Med J Aust; 2001 Sep; 175(5):258-63. PubMed ID: 11587258
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tinzaparin safety and efficacy in pregnancy.
    Khalifeh A; Grantham J; Byrne J; Murphy K; McAuliffe F; Byrne B
    Ir J Med Sci; 2014 Jun; 183(2):249-52. PubMed ID: 23934436
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Low-molecular-weight heparins in pregnancy.
    Ensom MH; Stephenson MD
    Pharmacotherapy; 1999 Sep; 19(9):1013-25. PubMed ID: 10610007
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Low molecular weight heparin-induced skin necrosis-a systematic review.
    Handschin AE; Trentz O; Kock HJ; Wanner GA
    Langenbecks Arch Surg; 2005 Jun; 390(3):249-54. PubMed ID: 15570433
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevention and Management of Thromboembolism in Pregnancy When Heparins Are Not an Option.
    James AH
    Clin Obstet Gynecol; 2018 Jun; 61(2):228-234. PubMed ID: 29470181
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hypersensitivity reactions to low molecular weight heparins: different patterns of cross-reactivity in 3 patients.
    Juricic Nahal D; Cegec I; Erdeljic Turk V; Makar Ausperger K; Kraljickovic I; Simic I
    Can J Physiol Pharmacol; 2018 Apr; 96(4):428-432. PubMed ID: 28977756
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: tolerance of a new recombinant hirudin.
    Koch P; Münssinger T; Rupp-John C; Uhl K
    J Am Acad Dermatol; 2000 Apr; 42(4):612-9. PubMed ID: 10727306
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Does Use of Low-Molecular-Weight Heparin during Pregnancy Influence the Risk of Prolonged Labor: A Population-Based Cohort Study.
    Sandström A; Cnattingius S; Wikström AK; Stephansson O; Iliadou AN
    PLoS One; 2015; 10(10):e0140422. PubMed ID: 26465918
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immediate Type Hypersensitivity to Heparins: Two Case Reports and a Review of the Literature.
    Cesana P; Scherer K; Bircher AJ
    Int Arch Allergy Immunol; 2016; 171(3-4):285-289. PubMed ID: 28049195
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of low molecular weight heparin (dalteparin) on duration and initiation of labour.
    Isma N; Svensson PJ; Lindblad B; Lindqvist PG
    J Thromb Thrombolysis; 2010 Aug; 30(2):149-53. PubMed ID: 19949968
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antithrombin concentrate during pregnancy in congenital antithrombin deficiency: a single-center experience.
    Bruzzese A; Santoro C; Baldacci E; Ferretti A; Pieroni S; Serrao A; Foà R; Chistolini A
    Blood Coagul Fibrinolysis; 2019 Sep; 30(6):304-307. PubMed ID: 31419212
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Everything the clinician needs to know about evidence-based anticoagulation in pregnancy.
    Scheres LJJ; Bistervels IM; Middeldorp S
    Blood Rev; 2019 Jan; 33():82-97. PubMed ID: 30107951
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Skin necrosis at the injection site induced by low-molecular-weight heparin: case report and review.
    Santamaría A; Romaní J; Souto JC; López A; Mateo J; Fontcuberta J
    Dermatology; 1998; 196(2):264-5. PubMed ID: 9568422
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Low-molecular weight heparins in pregnancy].
    Aguilera C; Vallano A
    Med Clin (Barc); 2002 May; 118(16):634-5. PubMed ID: 12028918
    [No Abstract]   [Full Text] [Related]  

  • 79. Delayed-type hypersensitivity skin reactions to low molecular weight heparins in a pregnant woman.
    Mora A; Belchi J; Contreras L; Rubio G
    Contact Dermatitis; 2002 Sep; 47(3):177-8. PubMed ID: 12492563
    [No Abstract]   [Full Text] [Related]  

  • 80. Low molecular weight heparin as cause of liver injury: case report and literature review.
    Leo M; Ponziani FR; Nesci A; Santoliquido A; Vecchio FM; Francalanci P; Pompili M
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7649-7654. PubMed ID: 31539157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.